East India Pharmaceutical Works Limited
₹79▲0.00%(0.00)
About the company
East India Pharmaceutical Works Limited (EIPWL) is one of India's oldest and most respected pharmaceutical companies, with a legacy that dates back to 1936. Headquartered in Kolkata, West Bengal, the company has been serving the healthcare industry for more than eight decades by developing, manufacturing, and marketing a wide range of pharmaceutical and healthcare products. Its long-standing presence reflects a commitment to quality, reliability, and continuous innovation in meeting the evolving healthcare needs of patients and medical professionals.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | — |
| 52 week low | — |
| P/B ratio | 0.78 |
| Debt to equity | 0.92 |
| ROE (%) | 3.47% |
| Book value | ₹101.38 |
| Face value | ₹10 |
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| P/B ratio | 0.78 |
| Debt | 47.9% of capital |
| Equity | 52.1% of capital |
| ROE (%) | 3.47% |
Registry
| Metric | Value |
|---|---|
| ISIN number | INE254X01017 |
Figures in cr ·
Financials
| P&L Statement | 2025Latest | 2024 | 2023 |
|---|---|---|---|
| Revenue | 272 | 250 | 234 |
| EBITDA | 13 | 12.4 | 10 |
| OPM | 4.78 | 4.96 | 4.27 |
| PBT | 4 | 4.5 | 2.4 |
| PAT | 2 | 3.8 | 1.7 |
| EPS | 3 | 5.7 | 2.55 |
Shareholding Pattern
Promoters
Others
| Holder | Percentage |
|---|---|
| Promoters | 25.87% |
| Others | 74.13% |
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| D. Duttagupta | Managing Director | 30+ yrs experience | — |
| Mrs. S. Mukherjee | Director | 25+ yrs experience | — |
| S. Ray | CFO | 30+ yrs experience | — |
Frequently asked questions
Common questions on East India Pharmaceutical Works Limited—tap a row to read the answer.
Q.1What are East India Pharmaceutical Works Limited unlisted shares?
East India Pharmaceutical Works Limited unlisted shares are equity shares of the company that are not traded on any recognized stock exchange. These shares are bought and sold through private transactions in the unlisted market, offering investors an opportunity to invest in the company before any potential public listing.
Q.2How can I buy East India Pharmaceutical Works Limited unlisted shares?
You can purchase East India Pharmaceutical Works Limited unlisted shares through registered brokers or intermediaries that specialize in unlisted share transactions. Once the buyer and seller agree on the price and quantity, the necessary documentation is completed, and the shares are transferred to the buyer's Demat account.
Q.3Is it legal to invest in East India Pharmaceutical Works Limited unlisted shares?
Yes. Buying and selling East India Pharmaceutical Works Limited unlisted shares is legal in India when the transaction follows applicable laws and regulatory guidelines. Investors should ensure that the shares are transferred through valid procedures and credited to their Demat account.
Q.4Why do investors consider East India Pharmaceutical Works Limited unlisted shares?
Many investors consider East India Pharmaceutical Works Limited unlisted shares because of the company's long operating history, established presence in the pharmaceutical industry, and potential for future business growth. However, investment decisions should always be based on careful analysis of the company's financial performance, valuation, and long-term prospects.
Q.5What should I evaluate before investing in East India Pharmaceutical Works Limited unlisted shares?
Before investing, review the company's financial statements, revenue and profit trends, product portfolio, management team, manufacturing capabilities, debt position, competitive strengths, and future growth strategy. Assessing these factors can help you determine whether the investment aligns with your financial goals.
Q.6Can I sell East India Pharmaceutical Works Limited unlisted shares whenever I want?
Yes, provided there is a willing buyer. Since unlisted shares are traded privately rather than on stock exchanges, the time required to complete the transaction depends on buyer availability, mutually agreed pricing, and the completion of transfer formalities.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

Unlisted Shares Price List India | Buy Pre IPO Shares Online
The Unlisted Shares Price List India helps investors track the latest prices of privately traded companies before they are listed on stock exchanges. This guide explains what Unlisted Shares and Pre IPO Shares are, how their prices are determined, and the factors that influence their valuation. It also covers the benefits, risks, taxation, and step-by-step process of buying unlisted shares in India. Additionally, the article highlights popular companies such as NSE India, OYO, API Holding (Pharm Easy), MSEI, Gamma Rotors, Zepto, Orbis Financial, and Motilal Oswal Home Finance, providing readers with a comprehensive understanding of India's growing pre-IPO market. Whether you're a new or experienced investor, this guide offers practical insights to help you make informed investment decisions.

NSE IPO Moves Closer: SEBI Approval Expected by Mid-August, Listing May Happen in September
The National Stock Exchange (NSE) IPO is moving closer to listing, with SEBI's approval for the IPO draft expected by mid-August 2026, according to NDTV Profit sources. If the remaining regulatory process is completed on time, NSE could be listed in September 2026, subject to final approvals and market conditions. A key development is the expected final settlement order in the NSE co-location case, with the settlement amount likely to exceed ₹1,400 crore. Meanwhile, NSE has reportedly begun domestic and international investor roadshows as part of its IPO preparations. While these updates indicate strong momentum toward the IPO, the final timeline remains subject to SEBI approval and official announcements.

NCDEX Launches 'Nidhi' Mutual Fund Platform: A New Chapter in India's Financial Inclusion Journey
NCDEX has launched the 'Nidhi' Mutual Fund Platform, marking a significant step toward expanding financial inclusion across rural and semi-urban India. The platform aims to simplify mutual fund investments by leveraging NCDEX's extensive FPO and agri-network, making investment opportunities more accessible to underserved communities. With six leading Asset Management Companies (AMCs) onboard at launch, the initiative seeks to encourage wider participation in India's mutual fund ecosystem and promote long-term wealth creation. Discover the key features, benefits, and potential impact of the NCDEX Nidhi Mutual Fund Platform, and learn how this strategic move strengthens NCDEX's presence beyond commodity markets while supporting the growth of India's financial ecosystem.

AirLife Gases Business Model, Growth Strategy & Valuation: A Complete Analysis
AirLife Gases is emerging as a key player in India's specialty gas industry with a strong focus on helium supply, infrastructure, and global expansion. Explore its business model, valuation, growth strategy, financial outlook, and the potential of AirLife Gases unlisted shares.

Why Sustainable Investing in Unlisted Shares is Becoming the Smart Choice for Indians
Sustainable investing in unlisted shares is becoming an increasingly popular choice among Indian investors who want to combine long-term wealth creation with responsible investing. By investing in high-growth private companies that follow strong Environmental, Social, and Governance (ESG) practices, investors can support innovation while potentially earning attractive returns. Although unlisted shares involve risks such as lower liquidity and valuation challenges, careful research, diversification, and a long-term investment approach can help manage these risks. If you're looking to invest in unlisted shares, visit Dhankirti.co.in to explore trusted investment opportunities and expert guidance.

Risks and Rewards of Investing in Unlisted Shares in India
Learn how to invest in unlisted shares in India. Explore high-growth opportunities, understand risks, and discover proven strategies. Expert guide with step-by-step process.
